Acrolein modification impairs key functional features of rat apolipoprotein E: Identification of modified sites by mass spectrometry

Biochemistry

Volumn 53, Issue 2, 2014, Pages 361-375

  Tran, Tuyen N ^a   Kosaraju, Malathi G ^b   Tamamizu Kato, Shiori ^b   Akintunde, Olayemi ^b   Zheng, Ying ^c   Bielicki, John K ^c   Pinkerton, Kent ^d   Uchida, Koji ^e   Lee, Yuan Yu ^a   Narayanaswami, Vasanthy ^a,b  

^a CALIFORNIA STATE UNIVERSITY   (United States)

^b CHILDREN S HOSPITAL OAKLAND RESEARCH INSTITUTE   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

^e NAGOYA UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN E (APOE); ATHEROSCLEROTIC LESIONS; ENVIRONMENTAL TOBACCO SMOKES; FLIGHT MASS SPECTROMETRY; FUNCTIONAL INTEGRITIES; LOW DENSITY LIPOPROTEINS; MATRIX ASSISTED LASER DESORPTION; OXIDATIVE MODIFICATION;

AMINO ACIDS; CHOLESTEROL; HERBICIDES; LIPOPROTEINS; MASS SPECTROMETRY; METABOLISM; PHYSIOLOGY; RATS; RECOMBINANT PROTEINS;

ALDEHYDES;

ACROLEIN; ALDEHYDE; APOLIPOPROTEIN E; CHOLESTEROL; GUANIDINE; HEPARIN BINDING PROTEIN; INTERLEUKIN 26; K135 PROTEIN; K138 PROTEIN; K149 PROTEIN; K254 PROTEIN; K64 PROTEIN; K67 PROTEIN; LIPID BINDING PROTEIN; LIPOPROTEIN; LYSINE DERIVATIVE; N (3 FORMYL 3,4 DEHYDROPIPERIDINO)LYSINE; N (3 METHYLPYRIDINIUM)LYSINE; OIL; PROPIONALDEHYDE; PROTEIN; TOBACCO SMOKE; UNCLASSIFIED DRUG;

AIR FILTER; AIR POLLUTANT; ANIMAL EXPERIMENT; ARTICLE; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; ENVIRONMENTAL EXPOSURE; IMMUNOPRECIPITATION; LIPID METABOLISM; LIPID PEROXIDATION; MALE; MASS SPECTROMETRY; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; NONHUMAN; PRIORITY JOURNAL; PROTEIN CROSS LINKING; PROTEIN MODIFICATION; PROTEIN STABILITY; RAT; TIME OF FLIGHT MASS SPECTROMETRY;

ACROLEIN; AMINO ACID SEQUENCE; ANIMALS; APOLIPOPROTEINS E; HUMANS; MALE; MASS SPECTROMETRY; MODELS, MOLECULAR; MOLECULAR SEQUENCE DATA; RATS; RATS, SPRAGUE-DAWLEY; RECOMBINANT PROTEINS;

EID: 84892695616     PISSN: 00062960     EISSN: 15204995     Source Type: Journal    
DOI: 10.1021/bi401404u     Document Type: Article

References (84)

1. Mahley, R. W., Weisgraber, K. H., and Huang, Y. (2009) Apolipoprotein E: Structure determines function, from atherosclerosis to Alzheimer's disease to AIDS J. Lipid. Res. 50 (Suppl) S183-188
2. Hauser, P. S., Narayanaswami, V., and Ryan, R. O. (2010) Apolipoprotein E: From lipid transport to neurobiology Prog. Lipid Res. 50, 62-74
3. Hatters, D. M., Peters-Libeu, C. A., and Weisgraber, K. H. (2006) Apolipoprotein E structure: Insights into function Trends Biochem. Sci. 31, 445-454
4. Narayanaswami, V., Maiorano, J. N., Dhanasekaran, P., Ryan, R. O., Phillips, M. C., Lund-Katz, S., and Davidson, W. S. (2004) Helix orientation of the functional domains in apolipoprotein e in discoidal high density lipoprotein particles J. Biol. Chem. 279, 14273-14279
5. Weisgraber, K. H. (1994) Apolipoprotein E: Structure-function relationships Adv. Protein Chem. 45, 249-302
6. von Eckardstein, A., Nofer, J. R., and Assmann, G. (2001) High density lipoproteins and arteriosclerosis. Role of cholesterol efflux and reverse cholesterol transport Arterioscler. Thromb. Vasc. Biol. 21, 13-27
7. Shimano, H., Ohsuga, J., Shimada, M., Namba, Y., Gotoda, T., Harada, K., Katsuki, M., Yazaki, Y., and Yamada, N. (1995) Inhibition of diet-induced atheroma formation in transgenic mice expressing apolipoprotein E in the arterial wall J. Clin. Invest. 95, 469-476
8. Zhang, S. H., Reddick, R. L., Piedrahita, J. A., and Maeda, N. (1992) Spontaneous hypercholesterolemia and arterial lesions in mice lacking apolipoprotein E Science 258, 468-471
9. Kashyap, V. S., Santamarina-Fojo, S., Brown, D. R., Parrott, C. L., Applebaum-Bowden, D., Meyn, S., Talley, G., Paigen, B., Maeda, N., and Brewer, H. B., Jr. (1995) Apolipoprotein E deficiency in mice: Gene replacement and prevention of atherosclerosis using adenovirus vectors J. Clin. Invest. 96, 1612-1620
10. Ghiselli, G., Schaefer, E. J., Gascon, P., and Breser, H. B., Jr. (1981) Type III hyperlipoproteinemia associated with apolipoprotein E deficiency Science 214, 1239-1241
11. Kurosaka, D., Teramoto, T., Matsushima, T., Yokoyama, T., Yamada, A., Aikawa, T., Miyamoto, Y., and Kurokawa, K. (1991) Apolipoprotein E deficiency with a depressed mRNA of normal size Atherosclerosis 88, 15-20
12. Mabuchi, H., Koizumi, J., Shimizu, M., and Takeda, R. (1989) Development of coronary heart disease in familial hypercholesterolemia Circulation 79, 225-232
13. Gueraud, F., Atalay, M., Bresgen, N., Cipak, A., Eckl, P. M., Huc, L., Jouanin, I., Siems, W., and Uchida, K. (2010) Chemistry and biochemistry of lipid peroxidation products Free Radical Res. 44, 1098-1124
14. Grassi, D., Desideri, G., Ferri, L., Aggio, A., Tiberti, S., and Ferri, C. (2010) Oxidative stress and endothelial dysfunction: Say no to cigarette smoking! Curr. Pharm. Des. 16, 2539-2550
15. Steinberg, D. (2009) The LDL modification hypothesis of atherogenesis: an update J. Lipid. Res. 50 (Suppl) S376-381
16. Tsimikas, S. (2008) In vivo markers of oxidative stress and therapeutic interventions Am. J. Cardiol. 101, 34D-42D
17. Fraley, A. E. and Tsimikas, S. (2006) Clinical applications of circulating oxidized low-density lipoprotein biomarkers in cardiovascular disease Curr. Opin. Lipidol. 17, 502-509
18. Brown, M. S. and Goldstein, J. L. (1983) Lipoprotein metabolism in the macrophage: Implications for cholesterol deposition in atherosclerosis Annu. Rev. Biochem. 52, 223-261
19. Sevanian, A., Bittolo-Bon, G., Cazzolato, G., Hodis, H., Hwang, J., Zamburlini, A., Maiorino, M., and Ursini, F. (1997) LDL- is a lipid hydroperoxide-enriched circulating lipoprotein J. Lipid Res. 38, 419-428
20. Cazzolato, G., Avogaro, P., and Bittolo-Bon, G. (1991) Characterization of a more electronegatively charged LDL subfraction by ion exchange HPLC Free Radical Biol. Med. 11, 247-253
21. Watson, A. D., Leitinger, N., Navab, M., Faull, K. F., Horkko, S., Witztum, J. L., Palinski, W., Schwenke, D., Salomon, R. G., Sha, W., Subbanagounder, G., Fogelman, A. M., and Berliner, J. A. (1997) Structural identification by mass spectrometry of oxidized phospholipids in minimally oxidized low density lipoprotein that induce monocyte/endothelial interactions and evidence for their presence in vivo J. Biol. Chem. 272, 13597-13607
22. Subbanagounder, G., Watson, A. D., and Berliner, J. A. (2000) Bioactive products of phospholipid oxidation: isolation, identification, measurement and activities Free Radical Biol. Med. 28, 1751-1761
23. Ziouzenkova, O., Asatryan, L., Akmal, M., Tetta, C., Wratten, M. L., Loseto-Wich, G., Jurgens, G., Heinecke, J., and Sevanian, A. (1999) Oxidative cross-linking of ApoB100 and hemoglobin results in low density lipoprotein modification in blood. Relevance to atherogenesis caused by hemodialysis J. Biol. Chem. 274, 18916-18924
24. Steinberg, D., Parthasarathy, S., Carew, T. E., Khoo, J. C., and Witztum, J. L. (1989) Beyond cholesterol. Modifications of low-density lipoprotein that increase its atherogenicity N. Engl. J. Med. 320, 915-924
25. Navab, M., Berliner, J. A., Watson, A. D., Hama, S. Y., Territo, M. C., Lusis, A. J., Shih, D. M., Van Lenten, B. J., Frank, J. S., Demer, L. L., Edwards, P. A., and Fogelman, A. M. (1996) The Yin and Yang of oxidation in the development of the fatty streak. A review based on the 1994 George Lyman Duff Memorial Lecture Arterioscler. Thromb. Vasc. Biol. 16, 831-842
26. Quinn, M. T., Parthasarathy, S., Fong, L. G., and Steinberg, D. (1987) Oxidatively modified low density lipoproteins: a potential role in recruitment and retention of monocyte/macrophages during atherogenesis Proc. Natl. Acad. Sci. U. S. A. 84, 2995-2998
27. Stevens, J. F. and Maier, C. S. (2008) Acrolein: Sources, metabolism, and biomolecular interactions relevant to human health and disease Mol. Nutr. Food Res. 52, 7-25
28. Uchida, K., Kanematsu, M., Sakai, K., Matsuda, T., Hattori, N., Mizuno, Y., Suzuki, D., Miyata, T., Noguchi, N., Niki, E., and Osawa, T. (1998) Protein-bound acrolein: Potential markers for oxidative stress Proc. Natl. Acad. Sci. U. S. A. 95, 4882-4887
29. Tran, T. N., Kim, S. H., Gallo, C., Amaya, M., Kyees, J., and Narayanaswami, V. (2012) Biochemical and biophysical characterization of recombinant rat apolipoprotein E: Similarities to human apolipoprotein E3 Arch. Biochem. Biophys. 529, 18-25
30. Uchida, K., Kanematsu, M., Morimitsu, Y., Osawa, T., Noguchi, N., and Niki, E. (1998) Acrolein is a product of lipid peroxidation reaction. Formation of free acrolein and its conjugate with lysine residues in oxidized low density lipoproteins J. Biol. Chem. 273, 16058-16066
31. Sreerama, N., Venyaminov, S. Y., and Woody, R. W. (2000) Estimation of protein secondary structure from circular dichroism spectra: Inclusion of denatured proteins with native proteins in the analysis Anal. Biochem. 287, 243-251
32. Morrow, J. A., Segall, M. L., Lund-Katz, S., Phillips, M. C., Knapp, M., Rupp, B., and Weisgraber, K. H. (2000) Differences in stability among the human apolipoprotein E isoforms determined by the amino-terminal domain Biochemistry 39, 11657-11666
33. Patel, A. B., Khumsupan, P., and Narayanaswami, V. (2010) Pyrene fluorescence analysis offers new insights into the conformation of the lipoprotein-binding domain of human apolipoprotein E Biochemistry 49, 1766-1775
34. Wetterau, J. R., Aggerbeck, L. P., Rall, S. C., Jr., and Weisgraber, K. H. (1988) Human apolipoprotein E3 in aqueous solution. I. Evidence for two structural domains J. Biol. Chem. 263, 6240-6248
35. Pace, C. N. and Vanderburg, K. E. (1979) Determining globular protein stability: Guanidine hydrochloride denaturation of myoglobin Biochemistry 18, 288-292
36. Weers, P. M., Abdullahi, W. E., Cabrera, J. M., and Hsu, T. C. (2005) Role of buried polar residues in helix bundle stability and lipid binding of apolipophorin III: destabilization by threonine 31 Biochemistry 44, 8810-8816
37. Fisher, C. A., Narayanaswami, V., and Ryan, R. O. (2000) The lipid-associated conformation of the low density lipoprotein receptor binding domain of human apolipoprotein E J. Biol. Chem. 275, 33601-33606
38. Narayanaswami, V., Szeto, S. S., and Ryan, R. O. (2001) Lipid association-induced N- and C-terminal domain reorganization in human apolipoprotein E3 J. Biol. Chem. 276, 37853-37860
39. Raussens, V., Drury, J., Forte, T. M., Choy, N., Goormaghtigh, E., Ruysschaert, J. M., and Narayanaswami, V. (2005) Orientation and mode of lipid-binding interaction of human apolipoprotein E C-terminal domain Biochem. J. 387, 747-754
40. Fisher, C., Abdul-Aziz, D., and Blacklow, S. C. (2004) A two-module region of the low-density lipoprotein receptor sufficient for formation of complexes with apolipoprotein E ligands Biochemistry 43, 1037-1044
41. Kiss, R. S., Weers, P. M., Narayanaswami, V., Cohen, J., Kay, C. M., and Ryan, R. O. (2003) Structure-guided protein engineering modulates helix bundle exchangeable apolipoprotein properties J. Biol. Chem. 278, 21952-21959
42. Tamamizu-Kato, S., Wong, J. Y., Jairam, V., Uchida, K., Raussens, V., Kato, H., Ruysschaert, J. M., and Narayanaswami, V. (2007) Modification by acrolein, a component of tobacco smoke and age-related oxidative stress, mediates functional impairment of human apolipoprotein E Biochemistry 46, 8392-8400
43. Vedhachalam, C., Narayanaswami, V., Neto, N., Forte, T. M., Phillips, M. C., Lund-Katz, S., and Bielicki, J. K. (2007) The C-terminal lipid-binding domain of apolipoprotein E is a highly efficient mediator of ABCA1-dependent cholesterol efflux that promotes the assembly of high-density lipoproteins Biochemistry 46, 2583-2593
44. Bielicki, J. K., Zhang, H., Cortez, Y., Zheng, Y., Narayanaswami, V., Patel, A., Johansson, J., and Azhar, S. (2010) A new HDL mimetic peptide that stimulates cellular cholesterol efflux with high efficiency greatly reduces atherosclerosis in mice J. Lipid Res. 51, 1496-1503
45. Zheng, Y., Patel, A. B., Narayanaswami, V., Hura, G. L., Hang, B., and Bielicki, J. K. (2011) HDL mimetic peptide ATI-5261 forms an oligomeric assembly in solution that dissociates to monomers upon dilution Biochemistry 50, 4068-4076
46. Zhang, G., Ueberheide, B. M., Waldemarson, S., Myung, S., Molloy, K., Eriksson, J., Chait, B. T., Neubert, T. A., and Fenyo, D. (2010) Protein quantitation using mass spectrometry Methods Mol. Biol. 673, 211-222
47. Shao, B., Fu, X., McDonald, T. O., Green, P. S., Uchida, K., O'Brien, K. D., Oram, J. F., and Heinecke, J. W. (2005) Acrolein impairs ATP binding cassette transporter A1-dependent cholesterol export from cells through site-specific modification of apolipoprotein A-I J. Biol. Chem. 280, 36386-36396
48. Uchida, K., Kanematsu, M., Morimitsu, Y., Osawa, T., Noguchi, N., and Niki, E. (1998) Acrolein is a product of lipid peroxidation reaction. Formation of free acrolein and its conjugate with lysine residues in oxidized low density lipoproteins J. Biol. Chem. 273, 16058-16066
49. Lambert, C., Li, J., Jonscher, K., Yang, T. C., Reigan, P., Quintana, M., Harvey, J., and Freed, B. M. (2007) Acrolein inhibits cytokine gene expression by alkylating cysteine and arginine residues in the NF-kappaB1 DNA binding domain J. Biol. Chem. 282, 19666-19675
50. Furuhata, A., Ishii, T., Kumazawa, S., Yamada, T., Nakayama, T., and Uchida, K. (2003) N(epsilon)-(3-methylpyridinium)lysine, a major antigenic adduct generated in acrolein-modified protein J. Biol. Chem. 278, 48658-48665
51. Jairam, V., Uchida, K., and Narayanaswami, V. (2012) Pathophysiology of lipoprotein oxidation, in Lipoproteins-Role in Health and Diseases (Frank, S. and Kostner, G., Eds.), InTech, Rijeka, Croatia.
52. Esterbauer, H., Schaur, R. J., and Zollner, H. (1991) Chemistry and biochemistry of 4-hydroxynonenal, malonaldehyde and related aldehydes Free Radical Biol. Med. 11, 81-128
53. Grundy, S. M. (1995) Role of low-density lipoproteins in atherogenesis and development of coronary heart disease Clin. Chem. 41, 139-146
54. Parthasarathy, S. and Rankin, S. M. (1992) Role of oxidized low density lipoprotein in atherogenesis Prog. Lipid Res. 31, 127-143
55. Dong, L. M., Wilson, C., Wardell, M. R., Simmons, T., Mahley, R. W., Weisgraber, K. H., and Agard, D. A. (1994) Human apolipoprotein E. Role of arginine 61 in mediating the lipoprotein preferences of the E3 and E4 isoforms J. Biol. Chem. 269, 22358-22365
56. Dong, L. M. and Weisgraber, K. H. (1996) Human apolipoprotein E4 domain interaction. Arginine 61 and glutamic acid 255 interact to direct the preference for very low density lipoproteins J. Biol. Chem. 271, 19053-19057
57. Raffai, R. L., Dong, L. M., Farese, R. V., Jr., and Weisgraber, K. H. (2001) Introduction of human apolipoprotein E4 "domain interaction" into mouse apolipoprotein E Proc. Natl. Acad. Sci. U. S. A. 98, 11587-11591
58. Mahley, R. W. and Ji, Z. S. (1999) Remnant lipoprotein metabolism: key pathways involving cell-surface heparan sulfate proteoglycans and apolipoprotein E J. Lipid Res. 40, 1-16
59. Ji, Z. S., Brecht, W. J., Miranda, R. D., Hussain, M. M., Innerarity, T. L., and Mahley, R. W. (1993) Role of heparan sulfate proteoglycans in the binding and uptake of apolipoprotein E-enriched remnant lipoproteins by cultured cells J. Biol. Chem. 268, 10160-10167
60. Jeon, H. and Blacklow, S. C. (2005) Structure and physiologic function of the low-density lipoprotein receptor Annu. Rev. Biochem. 74, 535-562
61. Fisher, C., Beglova, N., and Blacklow, S. C. (2006) Structure of an LDLR-RAP complex reveals a general mode for ligand recognition by lipoprotein receptors Mol. Cell 22, 277-283
62. Wilson, C., Wardell, M. R., Weisgraber, K. H., Mahley, R. W., and Agard, D. A. (1991) Three-dimensional structure of the LDL receptor-binding domain of human apolipoprotein E Science 252, 1817-1822
63. Morrow, J. A., Arnold, K. S., Dong, J., Balestra, M. E., Innerarity, T. L., and Weisgraber, K. H. (2000) Effect of arginine 172 on the binding of apolipoprotein E to the low density lipoprotein receptor J. Biol. Chem. 275, 2576-2580
64. Weisgraber, K. H., Innerarity, T. L., and Mahley, R. W. (1978) Role of lysine residues of plasma lipoproteins in high affinity binding to cell surface receptors on human fibroblasts J. Biol. Chem. 253, 9053-9062
65. Blacklow, S. C. (2007) Versatility in ligand recognition by LDL receptor family proteins: Advances and frontiers Curr. Opin. Struct. Biol. 17, 419-426
66. Prevost, M. and Raussens, V. (2004) Apolipoprotein E-low density lipoprotein receptor binding: study of protein-protein interaction in rationally selected docked complexes Proteins 55, 874-884
67. Guttman, M., Prieto, J. H., Croy, J. E., and Komives, E. A. (2010) Decoding of lipoprotein-receptor interactions: properties of ligand binding modules governing interactions with apolipoprotein E Biochemistry 49, 1207-1216
68. Mahley, R. W., Huang, Y., and Rall, S. C., Jr. (1999) Pathogenesis of type III hyperlipoproteinemia (dysbetalipoproteinemia). Questions, quandaries, and paradoxes J. Lipid Res. 40, 1933-1949
69. Futamura, M., Dhanasekaran, P., Handa, T., Phillips, M. C., Lund-Katz, S., and Saito, H. (2005) Two-step mechanism of binding of apolipoprotein E to heparin: Implications for the kinetics of apolipoprotein E-heparan sulfate proteoglycan complex formation on cell surfaces J. Biol. Chem. 280, 5414-5422
70. Libeu, C. P., Lund-Katz, S., Phillips, M. C., Wehrli, S., Hernaiz, M. J., Capila, I., Linhardt, R. J., Raffai, R. L., Newhouse, Y. M., Zhou, F., and Weisgraber, K. H. (2001) New insights into the heparan sulfate proteoglycan-binding activity of apolipoprotein E J. Biol. Chem. 276, 39138-39144
71. Weisgraber, K. H., Rall, S. C., Jr., Mahley, R. W., Milne, R. W., Marcel, Y. L., and Sparrow, J. T. (1986) Human apolipoprotein E. Determination of the heparin binding sites of apolipoprotein E3 J. Biol. Chem. 261, 2068-2076
72. Lund-Katz, S., Zaiou, M., Wehrli, S., Dhanasekaran, P., Baldwin, F., Weisgraber, K. H., and Phillips, M. C. (2000) Effects of lipid interaction on the lysine microenvironments in apolipoprotein E J. Biol. Chem. 275, 34459-34464
73. Lund-Katz, S., Wehrli, S., Zaiou, M., Newhouse, Y., Weisgraber, K. H., and Phillips, M. C. (2001) Effects of polymorphism on the microenvironment of the LDL receptor-binding region of human apoE J. Lipid Res. 42, 894-901
74. Zheng, Y., Kim, S. H., Patel, A. B., Narayanaswami, V., Iavarone, A. T., Hura, G. L., and Bielicki, J. K. (2012) The positional specificity of EXXK motifs within an amphipathic alpha-helix dictates preferential lysine modification by acrolein: Implications for the design of high-density lipoprotein mimetic peptides Biochemistry 51, 6400-6412
75. Nofer, J. R., Kehrel, B., Fobker, M., Levkau, B., Assmann, G., and von Eckardstein, A. (2002) HDL and arteriosclerosis: Beyond reverse cholesterol transport Atherosclerosis 161, 1-16
76. Krimbou, L., Denis, M., Haidar, B., Carrier, M., Marcil, M., and Genest, J., Jr. (2004) Molecular interactions between apoE and ABCA1: Impact on apoE lipidation J. Lipid Res. 45, 839-848
77. Remaley, A. T., Thomas, F., Stonik, J. A., Demosky, S. J., Bark, S. E., Neufeld, E. B., Bocharov, A. V., Vishnyakova, T. G., Patterson, A. P., Eggerman, T. L., Santamarina-Fojo, S., and Brewer, H. B. (2003) Synthetic amphipathic helical peptides promote lipid efflux from cells by an ABCA1-dependent and an ABCA1-independent pathway J. Lipid Res. 44, 828-836
78. Remaley, A. T., Stonik, J. A., Demosky, S. J., Neufeld, E. B., Bocharov, A. V., Vishnyakova, T. G., Eggerman, T. L., Patterson, A. P., Duverger, N. J., Santamarina-Fojo, S., and Brewer, H. B., Jr. (2001) Apolipoprotein specificity for lipid efflux by the human ABCAI transporter Biochem. Biophys. Res. Commun. 280, 818-823
79. Hara, H. and Yokoyama, S. (1991) Interaction of free apolipoproteins with macrophages. Formation of high density lipoprotein-like lipoproteins and reduction of cellular cholesterol J. Biol. Chem. 266, 3080-3086
80. Oram, J. F. and Yokoyama, S. (1996) Apolipoprotein-mediated removal of cellular cholesterol and phospholipids J. Lipid Res. 37, 2473-2491
81. Smith, J. D., Miyata, M., Ginsberg, M., Grigaux, C., Shmookler, E., and Plump, A. S. (1996) Cyclic AMP induces apolipoprotein E binding activity and promotes cholesterol efflux from a macrophage cell line to apolipoprotein acceptors J. Biol. Chem. 271, 30647-30655
82. Vedhachalam, C., Ghering, A. B., Davidson, W. S., Lund-Katz, S., Rothblat, G. H., and Phillips, M. C. (2007) ABCA1-induced cell surface binding sites for ApoA-I Arterioscler. Thromb. Vasc. Biol. 27, 1603-1609
83. Cominacini, L., Garbin, U., Davoli, A., Micciolo, R., Bosello, O., Gaviraghi, G., Scuro, L. A., and Pastorino, A. M. (1991) A simple test for predisposition to LDL oxidation based on the fluorescence development during copper-catalyzed oxidative modification J. Lipid Res. 32, 349-358
84. Shao, B., O'Brien, K. D., McDonald, T. O., Fu, X., Oram, J. F., Uchida, K., and Heinecke, J. W. (2005) Acrolein modifies apolipoprotein A-I in the human artery wall Ann. N.Y. Acad. Sci. 1043, 396-403